Publications by authors named "Samantha M Jaglowski"

30Publications

Safety of Axicabtagene Ciloleucel for the Treatment of Relapsed or Refractory Large B-Cell Lymphoma.

Clin Lymphoma Myeloma Leuk 2020 Oct 8. Epub 2020 Oct 8.

Arthur G. James Cancer Hospital and Richard J. Solove Research Institute, The Ohio State University, Columbus, OH.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.clml.2020.10.005DOI Listing
October 2020

A New Standard in Graft-versus-Host Disease Prophylaxis? An Introduction to Blood and Marrow Transplant Clinical Trials Network 1703.

Biol Blood Marrow Transplant 2020 Dec 10;26(12):e305-e308. Epub 2020 Sep 10.

Department of Hematology/Oncology, Mayo Clinic College of Medicine, Phoenix, Arizona. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.bbmt.2020.08.029DOI Listing
December 2020

A Pilot Study of Lenalidomide Maintenance Therapy after Autologous Transplantation in Relapsed or Refractory Classical Hodgkin Lymphoma.

Biol Blood Marrow Transplant 2020 Dec 20;26(12):2223-2228. Epub 2020 Aug 20.

Division of Oncology, Washington University School of Medicine, St. Louis, Missouri. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.bbmt.2020.08.017DOI Listing
December 2020

Second cancer incidence in CLL patients receiving BTK inhibitors.

Leukemia 2020 Dec 23;34(12):3197-3205. Epub 2020 Jul 23.

Department of Internal Medicine, Division of Hematology, Arthur G James Comprehensive Cancer Center, The Ohio State University Wexner Medical Center, Columbus, OH, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/s41375-020-0987-6DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7688551PMC
December 2020

Fluoroquinolone Prophylaxis in Autologous Stem Cell Transplantation: Worthy of a Second Look.

Biol Blood Marrow Transplant 2020 Aug 15;26(8):e198-e201. Epub 2020 Apr 15.

Division of Hematology, Department of Internal Medicine, The Ohio State University, Columbus, Ohio.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.bbmt.2020.03.027DOI Listing
August 2020

Running the tank to empty: how far can the CAR go?

Blood 2019 04;133(15):1617-1618

The Ohio State University.

View Article

Download full-text PDF

Source
http://www.bloodjournal.org/lookup/doi/10.1182/blood-2019-02
Publisher Site
http://dx.doi.org/10.1182/blood-2019-02-900761DOI Listing
April 2019

Tocilizumab as first-line therapy for steroid-refractory acute graft-versus-host-disease: analysis of a single-center experience.

Leuk Lymphoma 2019 09 15;60(9):2223-2229. Epub 2019 Feb 15.

Department of Pharmacy, The James Cancer Hospital, The Ohio State University Comprehensive Cancer Center , Columbus , Ohio , 43210 , USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1080/10428194.2019.1573996DOI Listing
September 2019

How ibrutinib, a B-cell malignancy drug, became an FDA-approved second-line therapy for steroid-resistant chronic GVHD.

Blood Adv 2018 08;2(15):2012-2019

Division of Blood and Marrow Transplantation, Department of Pediatrics, The University of Minnesota, Minneapolis, MN.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1182/bloodadvances.2018013060DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6093735PMC
August 2018

Road trip to remission with CARs.

Blood 2017 11;130(21):2240

THE OHIO STATE UNIVERSITY.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1182/blood-2017-10-808584DOI Listing
November 2017

The regulation of tumor-suppressive microRNA, miR-126, in chronic lymphocytic leukemia.

Cancer Med 2017 Apr 15;6(4):778-787. Epub 2017 Mar 15.

Division of Hematology, Department of Internal Medicine and Comprehensive Cancer Center, The Ohio State University, Columbus, Ohio.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/cam4.996DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5387133PMC
April 2017

A phase 2 trial of alisertib in patients with relapsed or refractory B-cellnon-Hodgkin lymphoma.

Leuk Lymphoma 2017 09 20;58(9):1-2. Epub 2017 Feb 20.

b Division of Hematology , The Ohio State University James Comprehensive Cancer Center , Columbus , OH , USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1080/10428194.2017.1289527DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5497734PMC
September 2017

Ibrutinib for treatment of chronic lymphocytic leukemia.

Am J Health Syst Pharm 2016 Mar;73(6):367-75

Division of Hematology, Ohio State University Comprehensive Cancer Center, Arthur G. James Cancer Hospital and Solove Research Institute, Columbus, OH.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.2146/ajhp140760DOI Listing
March 2016

Transplant for CLL: still an option?

Blood 2014 Dec;124(26):3835-6

THE OHIO STATE UNIVERSITY.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1182/blood-2014-10-606871DOI Listing
December 2014

Resistance mechanisms for the Bruton's tyrosine kinase inhibitor ibrutinib.

N Engl J Med 2014 Jun 28;370(24):2286-94. Epub 2014 May 28.

From the Division of Hematology, Department of Internal Medicine (J.A.W., T.-M.L., A.S.R., S.M.J., K.A.B., A.L., A.J.J., J.C. Byrd), the Department of Biomedical Informatics (H.G.O., A.S.Y.), and the Department of Pathology (G.L.), Ohio State University, Columbus; the Department of Medicine, Division of Hematology-Oncology, Weill Cornell Medical College, New York (R.R.F.); the Division of Molecular Genetics, German Cancer Research Center, Heidelberg (M.Z., P.L.), and the Department of Internal Medicine III, University of Ulm, Ulm (S.S.) - both in Germany; Pharmacyclics, Sunnyvale, CA (L.X., D.H.-H.L., S.M.S., D.F.J., J.J.B., B.Y.C.); the Duke Cancer Institute, Duke University, Durham, NC (S.S.D., J.Z.); the Division of Hematology-Oncology, Department of Medicine, Hofstra North Shore-LIJ School of Medicine, New Hyde Park, NY (J.C. Barrientos); and Janssen Research and Development, Beerse, Belgium (M.V.).

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1056/NEJMoa1400029DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4144824PMC
June 2014

Graft-versus-host disease: why have we not made more progress?

Curr Opin Hematol 2014 Mar;21(2):141-7

Division of Hematology, Department of Internal Medicine, The Ohio State University, Columbus, Ohio, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/MOH.0000000000000026DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4131840PMC
March 2014

Novel therapies and their integration into allogeneic stem cell transplant for chronic lymphocytic leukemia.

Biol Blood Marrow Transplant 2012 Jan;18(1 Suppl):S132-8

Department of Internal Medicine, Division of Hematology and Oncology, Comprehensive Cancer Center at The Ohio State University, Columbus, Ohio, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.bbmt.2011.11.018DOI Listing
January 2012

The clinical application of monoclonal antibodies in chronic lymphocytic leukemia.

Blood 2010 Nov 7;116(19):3705-14. Epub 2010 Jul 7.

Division of Hematology-Oncology, Department of Internal Medicine, College of Medicine, The Ohio State University, Columbus, OH, USA.

View Article

Download full-text PDF

Source
http://www.bloodjournal.org/cgi/doi/10.1182/blood-2010-04-00
Publisher Site
http://dx.doi.org/10.1182/blood-2010-04-001230DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2981531PMC
November 2010

Rituximab in chronic lymphocytic leukemia.

Semin Hematol 2010 Apr;47(2):156-69

Division of Hematology-Oncology, Department of Medicine, The Ohio State University, Columbus, OH.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1053/j.seminhematol.2010.01.005DOI Listing
April 2010

Lovenox hurts.

Ann Intern Med 2009 Oct;151(8):585-6

The Ohio State University, Columbus, OH 43210, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.7326/0003-4819-151-8-200910200-00015DOI Listing
October 2009

Lymphoma in adolescents and young adults.

Semin Oncol 2009 Oct;36(5):381-418

Department of Hematology, The Ohio State University, Columbus, OH, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1053/j.seminoncol.2009.07.009DOI Listing
October 2009